TaiwanJ Pharmaceuticals Co., Ltd. (TPEX: 6549)
Health Care · Biotechnology · TW
NT$6.89
-2.13% today · -12.0% 1Y
TaiwanJ Pharmaceuticals Co., Ltd. (TPEX: 6549) operates in the Biotechnology industry within the Health Care sector. The company is valued at $17.01M and employs 13 people.
Over the last twelve months the share price has lost 12.0%, trading between 6.21 and 9.80.
Tweenvest scores TaiwanJ Pharmaceuticals Co., Ltd. across four factors: quality 52/100, value 51/100. Its strongest factor is quality.
6549 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $17.01M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.23
- Dividend yield
- —
- Beta (5Y)
- -1.12
- 52-week high
- NT$9.80
- 52-week low
- NT$6.21
- Avg volume (3M)
- —
- Shares outstanding
- 80.12M
- Employees
- 13
- Next earnings
- —
About TaiwanJ Pharmaceuticals Co., Ltd.
TaiwanJ Pharmaceuticals Co., Ltd. operates as a specialized biotech firm dedicated to the research, development, and commercialization of small molecule therapeutics. Initially, its focus within Taiwan has been on tackling chronic organ inflammation stemming from metabolic, autoimmune, or infectious causes. The company's growing pipeline also features specific compounds like JKB-122 and JKB-121, alongside a collection of innovative chemical entities. These new drugs are being developed to address persistent liver conditions and allergic respiratory ailments, such as asthma. TaiwanJ's comprehensive product portfolio is engineered to combat a wide array of diseases, encompassing hepatic inflammation and fibrosis, non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), various autoimmune disorders, asthma, and atopic dermatitis (eczema). Established in 2011, the company's operations are headquartered in Zhubei, Taiwan.
- ISIN
- TW0006549009
- Founded
- 2011
- Listed since
- Oct 21, 2015
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| CCME Global LimitedBSE: 514336 | $17.68M | Rs37.09 | +15.44% |
| Perseus Proteomics Inc.TSE: 4882 | $17.63M | ¥151.00 | -1.31% |
| Marker Therapeutics, Inc.NasdaqCM: MRKR | $17.34M | $1.04 | +7.04% |
| Diamyd Medical AB (publ)OM: DMYD B | $17.06M | Skr1.09 | +11.22% |
| Urteste S.A.WSE: URT | $16.82M | zł42.80 | +0.23% |
| NeuroScientific Biopharmaceuticals LimitedASX: NSB | $16.54M | AU$0.06 | +5.17% |
| Daesung Microbiological Labs. Co., Ltd.KOSDAQ: A036480 | $16.50M | ₩5,790.00 | -3.50% |
| Vectorite Biomedical Inc.TPEX: 4170 | $16.46M | NT$12.20 | -2.79% |
Figures last refreshed Oct 18, 2026.